Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT02465359 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

DRUG: Immune Globulin Subcutaneous (Human)

Sponsor

University of South Florida

Collaborators

[object Object]